Click HERE to Access the Teams Recording
Beacon GLP-1 Agonist Presentation 1
Overcoming The Agonies of GLP1 Agonists
Presented By: Michael Campbell, PharmD, BCACP
Mayo Clinic
Learning Objectives
- Review FDA indications for use of GLP-1/GIP RAs
- Understand provider-pharmacist collaboration surrounding GLP-1/GIP therapy
- Describe challenges with cost-effective procurement of GLP-1 therapy
Dr. Campbell provides medication therapy management services under a collaborative practice agreement in Mayo Clinic Arizona’s family medicine department. He partners with physicians, advanced practice nurse practitioners, and physician assistants to improve patient outcomes for a wide array of diseases states. His primary care practice has a special focus on diabetes, hypertension, hyperlipidemia, obesity, depression, and anxiety. He obtained his pharmacy degree from the University of Arizona College of Pharmacy where he serves as clinical adjunct faculty precepting doctor of pharmacy candidates during their advanced practice clinical rotations.
